novo nordisk weight loss drug - Search News

Novo Nordisk cuts price of weight-loss drug for uninsured

Reuters on MSN · 8m

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst Lange told an online press conference on Thursday. GLP-1 drugs on the market include Novo Nordisk's diabetes drug Ozempic,

USA TODAY on MSN · 22h

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.

The New York Times · 23h

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move ...

1don MSN

Amgen starts two critical late-stage trials for weight loss drug MariTide

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...

1don MSN

Down 39%. Is Novo Nordisk Stock a Buy on the Dip?

Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results